SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-24-000107
Filing Date
2024-05-07
Accepted
2024-05-07 07:05:38
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20240331.htm   iXBRL 10-Q 1333460
2 EX-31.1 zentalis10-qq12024ex311.htm EX-31.1 10882
3 EX-31.2 zentalis10-qq12024ex312.htm EX-31.2 11119
4 EX-32.1 zentalis10-qq12024ex321.htm EX-32.1 5585
5 EX-32.2 zentalis10-qq12024ex322.htm EX-32.2 5129
11 zntl-20240331_g1.jpg GRAPHIC 169140
  Complete submission text file 0001725160-24-000107.txt   6535156

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20240331.xsd EX-101.SCH 37144
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20240331_cal.xml EX-101.CAL 77717
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20240331_def.xml EX-101.DEF 173825
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20240331_lab.xml EX-101.LAB 527624
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20240331_pre.xml EX-101.PRE 371802
75 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20240331_htm.xml XML 720773
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 24919562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)